An expanded treatment protocol of panobinostat in combination therapy for relapsed and relapsed and refractory (RR) cancer of plasma cells

Update Il y a 4 ans
Reference: EUCTR2014-003239-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

- To provide multiple myeloma patients early access to treatment with panobinostat and to further evaluate safety of panobinostat when used in combination with BTZ/Dex in patients with multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory agent.


Inclusion criteria

  • Multiple myeloma